# Continuation of Subcutaneous and Intramuscular Depot Medroxyprogesterone Acetate in Post-abortion Patients

> **NCT05505435** · PHASE4 · COMPLETED · sponsor: **Northwestern University** · enrollment: 263 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** Depot-Medroxyprogestereone Acetate
- **DRUG:** Depot-Medroxyprogestereone Acetate

## Key facts

- **NCT ID:** NCT05505435
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-01
- **Primary completion:** 2023-09-30
- **Final completion:** 2024-03-30
- **Target enrollment:** 263 (ACTUAL)
- **Last updated:** 2026-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05505435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05505435, "Continuation of Subcutaneous and Intramuscular Depot Medroxyprogesterone Acetate in Post-abortion Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05505435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*